Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fulminant colitis.
Portela F, Lago P. Portela F, et al. Best Pract Res Clin Gastroenterol. 2013 Oct;27(5):771-82. doi: 10.1016/j.bpg.2013.08.011. Epub 2013 Sep 6. Best Pract Res Clin Gastroenterol. 2013. PMID: 24160933 Review.
Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis.
Magro F, Alves C, Santiago M, Ministro P, Lago P, Correia L, Gonçalves R, Carvalho D, Portela F, Dias CC, Dignass A, Danese S, Peyrin-Biroulet L, Estevinho MM, Moreira P; on behalf GEDII (Portuguese IBD Group). Magro F, et al. Among authors: portela f. United European Gastroenterol J. 2022 Feb;10(1):54-72. doi: 10.1002/ueg2.12183. Epub 2021 Dec 14. United European Gastroenterol J. 2022. PMID: 34907660 Free PMC article.
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.
Magro F, Lopes S, Silva M, Coelho R, Portela F, Branquinho D, Correia L, Fernandes S, Cravo M, Caldeira P, Sousa HT, Patita M, Lago P, Ramos J, Afonso J, Redondo I, Machado P, Cornillie F, Lopes J, Carneiro F; Portuguese IBD Group [GEDII]. Magro F, et al. Among authors: portela f. J Crohns Colitis. 2019 Oct 28;13(11):1387-1393. doi: 10.1093/ecco-jcc/jjz071. J Crohns Colitis. 2019. PMID: 30989180 Clinical Trial.
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
Magro F, Lopes SI, Lopes J, Portela F, Cotter J, Lopes S, Moreira MJ, Lago P, Peixe P, Albuquerque A, Rodrigues S, Silva MR, Monteiro P, Lopes C, Monteiro L, Macedo G, Veloso L, Camila C, Afonso J, Geboes K, Carneiro F; Portuguese IBD group [GEDII]. Magro F, et al. Among authors: portela f. J Crohns Colitis. 2016 Dec;10(12):1407-1416. doi: 10.1093/ecco-jcc/jjw112. Epub 2016 May 25. J Crohns Colitis. 2016. PMID: 27226417 Clinical Trial.
Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial.
Domènech E, Panés J, Hinojosa J, Annese V, Magro F, Sturniolo GC, Bossa F, Fernández F, González-Conde B, García-Sánchez V, Dignass A, Herrera JM, Cabriada JL, Guardiola J, Vecchi M, Portela F, Ginard D; ATTICA Study Group by the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa [listed at the end of the article]. Domènech E, et al. Among authors: portela f. J Crohns Colitis. 2018 May 25;12(6):687-694. doi: 10.1093/ecco-jcc/jjy023. J Crohns Colitis. 2018. PMID: 29490024 Clinical Trial.
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.
Magro F, Lopes S, Silva M, Coelho R, Portela F, Branquinho D, Correia L, Fernandes S, Cravo M, Caldeira P, Tavares de Sousa H, Patita M, Lago P, Ramos J, Afonso J, Redondo I, Machado P, Philip G, Lopes J, Carneiro F. Magro F, et al. Among authors: portela f. Therap Adv Gastroenterol. 2019 Aug 30;12:1756284819869141. doi: 10.1177/1756284819869141. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31516554 Free PMC article.
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review.
Estevinho MM, Rocha C, Correia L, Lago P, Ministro P, Portela F, Trindade E, Afonso J, Peyrin-Biroulet L, Magro F; GEDII (Portuguese IBD Group). Estevinho MM, et al. Among authors: portela f. Clin Gastroenterol Hepatol. 2020 May;18(5):1054-1069. doi: 10.1016/j.cgh.2019.08.063. Epub 2019 Sep 14. Clin Gastroenterol Hepatol. 2020. PMID: 31526845 Review.
183 results